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Abstract Variationsinthefat-massandobesity-associated
gene (FTO) are associated with the obesity phenotype in
many Caucasian populations. This association with the
obesityphenotypeisnotclearintheJapanese.Toinvestigate
the relationship between the FTO gene and obesity in the
Japanese, we genotyped single nucleotide polymorphisms
(SNPs) in the FTO genes from severely obese subjects
[n = 927,bodymassindex(BMI) C 30 kg/m
2]andnormal-
weight control subjects (n = 1,527, BMI\25 kg/m
2).
A case-control association analysis revealed that 15 SNPs,
including rs9939609 and rs1121980, in a linkage disequi-
librium (LD) block of approximately 50 kb demonstrated
signiﬁcant associations with obesity; rs1558902 was most
signiﬁcantly associated with obesity. P value in additive
mode was 0.0000041, and odds ratio (OR) adjusted for
age and gender was 1.41 [95% conﬁdential interval
(CI) = 1.22–1.62]. Obesity-associated phenotypes, which
include the level of plasma glucose, hemoglobin A1c, total
cholesterol, triglycerides, high-density lipoprotein (HDL)
cholesterol, and blood pressure were not associated with the
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Introduction
Obesity is the most common nutritional disorder in
developed countries, and it is a major risk factor for
hypertension, cardiovascular disease, and type 2 diabetes
(Kopelman 2000; Wilson et al. 2003). Genetic and envi-
ronmental factors contribute to obesity development (Maes
et al. 1997; Barsh et al. 2000; Rankinen et al. 2006). Recent
progress in single nucleotide polymorphism (SNP) geno-
typing techniques has enabled genome-wide association
studies on common diseases (Herbert et al. 2006; Frayling
et al. 2007; Scuteri et al. 2007; The Wellcome Trust Case
Control Consortium 2007; Hinney et al. 2007). Using a
large-scale case-control association study, we found that
secretogranin III (SCG3) (Tanabe et al. 2007) and myotu-
bularin-related protein 9 (MTMR9) (Yanagiya et al. 2007)
are involved in susceptibility to the obesity phenotype.
Genome-wide association studies have shown that the fat-
mass and obesity-associated gene (FTO) is also associated
with the obesity phenotype (Frayling et al. 2007; Scuteri
et al. 2007; Hinney et al. 2007). This association was also
found in many Caucasian and Hispanic American popula-
tions (Frayling et al. 2007; Scuteri et al. 2007; Dina et al.
2007; Field et al. 2007; Andreasen et al. 2008;W a ˚hle ´n
et al. 2008; Peeters et al. 2008), whereas it was not found in
the Chinese Han population (Li et al. 2008). Among Jap-
anese, body mass index (BMI) was higher in subjects who
had the A allele of rs9939609, similar to that observed in
Caucasians; however, this ﬁnding was not signiﬁcant
(Horikoshi et al. 2007). Another group reported that
rs9939609 was associated with BMI in the Japanese
(Omori et al. 2008). Thus, the association of SNPs in the
FTO gene with obesity in the Japanese remains
controversial.
To investigate the relationship between the FTO gene
and obesity in the Japanese, we performed a case-control
association study using patients with severe adult obesity
(BMI C 30 kg/m
2) and normal-weight controls
(BMI\25 kg/m
2); we found that SNPs in intron 1 of the
FTO gene were associated with severe adult obesity.
Materials and methods
Study subjects
The sample size for severely obese Japanese subjects
(BMI C 30 kg/m
2) was 927 (male:female ratio 419:508,
age 48.7 ± 14.2 years, BMI 34.2 ± 5.4 kg/m
2), whereas
thatforJapanesenormalweight controls(BMI\25 kg/m
2)
was 1,527 (male:female ratio 685:842, age 48.1 ±
16.5 years, BMI 21.7 ± 2.1 kg/m
2). The severely obese
subjects were recruited from among outpatients of medical
institutes. Patients with secondary obesity and obesity-
related hereditary disorders were not included, and neither
were patients with medication-induced obesity. The nor-
mal-weight controls were recruited from among subjects
who had undergone a medical examination for screening
of common diseases. Clinical features of the subjects
are illustrated in Table 1. Additionally, 1,604 subjects
were recruited (male:female ratio 803:801, age 48.7 ±
16.9 years, BMI 22.66 ± 3.16 kg/m
2) from the Japanese
general population. Each subject provided written informed
consent, and the protocol was approved by the ethics
committee of each institution and that of RIKEN.
DNA preparation and SNP genotyping
Genomic DNA was prepared from the blood sample of
each subject by using the Genomix (Talent Srl, Trieste,
Italy). We searched for dbSNPs with minor allele fre-
quencies (MAF)[0.10 in the FTO gene of Japanese
people. We selected 90 SNPs and were able to construct
Invader probes (Third Wave Technologies, Madison, WI)
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123for them (Supplementary Table 1). SNPs were genotyped
using Invader assays as described previously (Ohnishi et al.
2001; Takei et al. 2002). Nine SNPs (rs9937053,
rs9939973, rs9940128, rs7193144, rs8043757, rs9923233,
rs9926289, rs9939609, and rs9930506) reported in a pre-
vious genome-wide association study (Scuteri et al. 2007)
were genotyped using TaqMan probes (C__29910458_10,
C__11776771_10, C__29621384_10, C__29387650_10,
C__29387665_10, C__29693738_10, C__30270568_10,
C__30090620_10, and C__29819994_10; Applied Bio-
systems, Foster City, CA, USA).
Statistical analysis
Genotype or allele frequencies were compared between
cases and controls in three different modes. In the ﬁrst
mode, i.e., the additive mode, v
2 test was performed
according to Sladek et al. (Sladek et al. 2007). In the
second mode, i.e., the minor allele recessive mode, fre-
quencies of the homozygous genotype for the minor allele
were compared using a 2 9 2 contingency table. In the
third mode, i.e., the minor allele dominant mode, fre-
quencies of the homozygous genotype for the major allele
were compared using a 2 9 2 contingency table. A test of
independence was performed using Pearson’s v
2 method. P
values were corrected by Bonferroni adjustment and
P\0.00017 [0.05/99 (total SNP number)/3 (number of
modes)] was considered signiﬁcant. The odds ratio (OR)
and 95% conﬁdence interval (CI) were calculated by
Woolf’s method. We coded genotypes as 0, 1, and 2,
depending on the number of copies of the risk alleles. OR
adjusted for age and gender was calculated using multiple
logistic regression with genotypes, age, and gender as
independent variables. Hardy–Weinberg equilibrium was
assessed using the v
2 test (Nielsen et al. 1998). Haplotype
blocks were determined using Haploview (Barrett et al.
2005). Simple comparison of the clinical data among the
different genotypes was performed using one-way analysis
of variance (ANOVA). Simple comparison of the clinical
data between case and control groups was analyzed using
Mann–Whitney U test. Difference in BMI between geno-
types was analyzed using a multiple linear regression, with
BMI as the dependent variable and genotype as the inde-
pendent variable, and with gender and age as covariates for
BMI. Statistical analyses were performed using StatView
5.0 (SAS Institute, Cary, NC, USA). Power was calculated
by the Monte Carlo method.
Results
Case-control association studies
WesearchedfordbSNPswithMAF[0.10intheFTOgene.
By using Invader and TaqMan assay, we successfully gen-
otyped 99 SNPs spanning the FTO gene (Supplementary
Table 1). Using these SNPs, we performed tests of inde-
pendencebetweenthephenotypeandgenotypesofobesityat
eachSNPbyusingseverelyobesesubjects(BMI C 30 kg/m
2)
and normal weight controls (BMI\25 kg/m
2). For each
SNP, the lowest P value among the three different
modes was selected as the minimum P value. All SNPs,
including rs1421084, were in Hardy–Weinberg equilibrium
(P[0.01) (Supplementary Table 1).
The power of the test was calculated by Monte Carlo
method with different MAFs and different effect sizes.
Effect of the risk allele on penetrance was assumed to be
multiplicative; i.e., the penetrances for three genotypes
were assumed to be a, ar, and ar
2, respectively, where a and
r denote the lowest penetrance and genotype relative risk,
respectively. Supplementary Table 2 shows the calculated
values of the power of the test with different MAFs and
different genotype relative risks (r). The lowest penetrance
(a) was calculated for each gender by assuming the affec-
tion rates of 2.3% for men and 3.4% for women (Yoshiike
et al. 2002). Genotype relative risk (r) was assumed to be
Table 1 Clinical
characterization of obese and
control subjects
P values were analyzed using
Mann–Whitney U test. Data are
mean ± standard deviation
Obese Control P value
Gender (M/F) 419/508 658/842
Age (year) 49.1 ± 14.2 48.2 ± 16.5 0.049
Body mass index (kg/m
2) 34.50 ± 5.39 21.65 ± 2.08 \0.000001
Glucose (mg/dl) 129.2 ± 49.6 97.7 ± 23.9 \0.000001
HbA1c (%) 6.5 ± 1.8 5.1 ± 0.6 \0.000001
Total cholesterol (mg/dl) 209.9 ± 37.9 201.2 ± 36.4 \0.000001
Triglycerides (mg/dl) 153.2 ± 99.5 104.0 ± 73.2 \0.000001
High-density lipoprotein cholesterol (mg/dl) 53.1 ± 18.9 65.1 ± 15.7 \0.000001
Systolic blood pressure (mmHg) 136.4 ± 18.1 123.4 ± 17.8 \0.000001
Diastolic blood pressure (mmHg) 83.8 ± 12.0 76.0 ± 11.1 \0.000001
548 J Hum Genet (2008) 53:546–553
123the same for both genders. Supplementary Table 2 shows
that the test has signiﬁcant power at relative high risk allele
frequency when genotype relative risk is[1.7.
As shown in Fig. 1 and Supplementary Table 1, 15 SNPs
demonstrated signiﬁcant associations with the obesity
phenotype; the threshold of signiﬁcance using Bonfferoni
correction was P\0.00017. These SNPs included
rs9939609 (Frayling et al. 2007) and rs1121980 (Hinney
et al. 2007) that were reported to be signiﬁcantly associated
with the obesity phenotype in the Caucasian population, as
determined by genome-wide association studies; rs9930506
(Scuteri et al. 2007) showed marginal association with
obesity in the Japanese. Linkage disequilibrium (LD)
analysis revealed that these 15 SNPs were in almost com-
plete LD (D’[0.98, r
2[0.80) and were located within
the same LD block of approximately 50 kb (Fig. 1). The
most signiﬁcant association was observed for rs1558902
[additive mode, P = 0.0000041 and allele-speciﬁc OR
(95% CI) adjusted for age and gender was 1.41 (1.22–
1.62)]. The minor alleles of rs9939609 (MAF = 0.24) and
rs1121980 (MAF = 0.26) were signiﬁcantly more frequent
in the obese group than in the normal-weight control group
(additive mode, P = 0.000012 and P = 0.000051, respec-
tively), and ORs were 1.38 (95% CI = 1.20–1.59) and 1.33
(95% CI = 1.16–1.52), respectively (Table 2, Supplemen-
tary Table 1). The MAF of both SNPs in the control group
was 0.18; this was consistent with data obtained from the
haplotype map of the human genome (HapMap) (Supple-
mentary Table 1). Our data indicated that the SNPs in the
FTO gene were associated with severe obesity in the
Japanese.
Analysis of various quantitative phenotypes
with rs1558902
To investigate whether the genotypes of SNP rs1558902
are associated with the phenotypes of metabolic disorders,
we compared the following among the different genotypes
in the cases, controls, and combined groups: ANOVA
results, BMI, levels of fasting plasma glucose, hemoglobin
A1c (HbA1c), total cholesterol, triglycerides, HDL cho-
lesterol, and blood pressure. As rs1558902 showed the
most signiﬁcant association with obesity and its call rate
was the highest, we analyzed various quantitative pheno-
types by using this SNP. The quantitative phenotypes
regarding BMI and the levels of fasting plasma glucose,
HbA1c, total cholesterol, triglycerides, HDL cholesterol,
and blood pressure were not found to be signiﬁcantly
associated with the genotypes at rs1558902 in either the
case or control group (Table 3). Although there was no
signiﬁcant difference in BMI values among genotypes in
either the control or case group, the direction of the dif-
ference (AA[AT[TT) was in accordance with the
association between the qualitative obesity phenotype and
the genotype shown.
Finally, we examined the BMI distribution of rs1558902
in the Japanese general population and found that
rs1558902 genotype was signiﬁcantly associated with BMI
Fig. 1 Linkage disequilibrium
(LD) mapping, polymorphisms,
and P values obtained in the test
of independence between the
phenotype and genotypes of
obesity at various single
nucleotide polymorphisms
(SNPs) in the fat-mass and
obesity-associated gene (FTO)
gene. P values are expressed as
negative logarithm of the
minimum P values obtained in
the three models (additive,
minor allele dominant, and
minor allele recessive modes).
LD coefﬁcients (D’) between
each pair of SNPs were
calculated and are displayed as a
strand in the LD blocks. Minor
allele frequencies of all SNPs
used in this analysis are C10%.
The genomic structure is shown
in the upper. The gray bar
marks the LD block associated
with obesity
J Hum Genet (2008) 53:546–553 549
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123(Table 4). This result would conﬁrm the association of
rs1558902 with obesity.
Discussion
Recent genome-wide association studies have shown that
the FTO gene is associated with obesity (Frayling et al.
2007; Scuteri et al. 2007; Hinney et al. 2007). The asso-
ciations between variations in the FTO gene and the
obesity phenotype have been observed in many Caucasian
subjects (Frayling et al. 2007; Scuteri et al. 2007; Dina
et al. 2007; Field et al. 2007; Andreasen et al. 2008;
Wa ˚hle ´n et al. 2008; Peeters et al. 2008). However, these
associations were controversial with regard to Asian sub-
jects (Horikoshi et al. 2007; Li et al. 2008; Omori et al.
2008). BMI values did not signiﬁcantly differ among the
genotypes in the general population of Chinese and
Japanese (Horikoshi et al. 2007; Li et al. 2008). We per-
formed a case-control association study with regard to
severe obesity and found that the SNPs in the FTO gene
were signiﬁcantly associated with severe obesity. Although
the SNPs demonstrated the most signiﬁcant association in
the Japanese, which was different from that in Caucasians,
the signiﬁcantly associated SNPs existed in a similar block
as that in Caucasians. Therefore, the FTO gene could also
contribute to the development of severe obesity in the
Japanese.
BMI was modestly different among rs1558902 geno-
types in the general population in this study; rs9939609
was not signiﬁcantly associated with BMI in the general
population (AA 23.22 ± 3.14 vs AT 22.79 ± 3.25 vs TT
22.58 ± 3.13, P = 0.063). In the Japanese population,
rs1558902 may be more tightly associated with BMI than
rs9939609. The National Nutrition Survey of Japan
reported that the prevalence of subjects with a BMI of
Table 3 Comparison of various quantitative phenotypes among different genotypes at single nucleotide polymorphism (SNP) rs1558902 in
obese and control subjects
Obese Control
AA (n = 48) AT (n = 341) TT (n = 536) AA (n = 52) AT (n = 448) TT (n = 1022)
Age (year) 49.8 ± 15.3 49.6 ± 14.3 48.8 ± 14.1 46.9 ± 15.4 46.9 ± 16.7 48.8 ± 16.5
P value 0.64 0.098
BMI (kg/m
2) 35.16 ± 5.70 34.61 ± 5.43 34.39 ± 5.33 21.94 ± 2.23 21.62 ± 2.10 21.65 ± 2.06
P value 0.58 0.56
Glucose (mg/dl) 142.8 ± 54.8 125.4 ± 43.2 130.8 ± 53.3 101.7 ± 44.1 96.3 ± 18.1 98.2 ± 24.7
P value 0.054 0.34
HbA1c (%) 6.9 ± 2.1 6.4 ± 1.7 6.5 ± 1.8 5.1 ± 1.2 5.0 ± 0.5 5.1 ± 0.7
P value 0.19 0.15
Total cholesterol (mg/dl) 215.1 ± 46.7 211.3 ± 38.8 208.6 ± 36.6 195.6 ± 38.8 201.4 ± 37.8 201.4 ± 35.6
P value 0.37 0.53
Triglycerides (mg/dl) 171.7 ± 119.5 151.3 ± 102.1 153.2 ± 96.0 111.7 ± 70.6 102.0 ± 71.4 104.4 ± 74.2
P value 0.42 0.63
HDL cholesterol (mg/dl) 53.2 ± 13.8 54.8 ± 24.0 52.0 ± 15.4 62.1 ± 14.2 65.1 ± 15.9 65.3 ± 15.6
P value 0.14 0.53
SBP (mmHg) 134.2 ± 20.4 137.0 ± 17.8 136.2 ± 18.2 122.7 ± 17.3 123.2 ± 18.8 123.5 ± 17.5
P value 0.61 0.91
DBP (mmHg) 80.3 ± 11.7 84.1 ± 12.0 83.9 ± 12.0 75.5 ± 11.1 75.2 ± 11.7 76.3 ± 10.9
P value 0.14 0.22
Data of each quantitative phenotype were compared among different genotypes at the rs1558902 in obese and control subjects. P values were
analyzed using analysis of variance in each group of obese and control subjects. Data are mean ± standard deviation.
HDL high-density lipoprotein, SBP systolic blood pressure, DBP diastolic blood pressure.
Table 4 Association of body mass index (BMI) with rs1558902 genotypes in the Japanese general population
AA AT TT P value (additive model)
a
BMI (kg/m
2)( n) 23.17 ± 3.20 (59) 22.79 ± 3.26 (482) 22.57 ± 3.11 (1063) 0.041
a The difference in BMI according to genotypes was analyzed using a multiple linear regression, with BMI as the dependent variable and
genotype as the independent variable and with gender and age as covariates for BMI. Data are represented as mean ± standard deviation
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123C30 kg/m
2 is only 2.3% in men and 3.4% in women aged
20 years and older (Yoshiike et al. 2002), and the mean
BMI was approximately 23 kg/m
2 for ages 15–84 years
(Yoshiike et al. 1998). Inconsistency in the results of
effects of variations in the FTO gene on BMI between
Japanese and Europians may be due to the relatively small
mean and variance of BMI in the former than the latter.
The signiﬁcant SNPs were located in intron 1 of the
FTO gene. The rs1558902 and other signiﬁcant SNPs, for
example, rs9939609 and rs1121980, would affect tran-
scriptional activity of the FTO gene, although further
investigation is necessary. The precise mechanism by
which the FTO gene leads to obesity development is
unclear (Gerken et al. 2007; Sanchez-Pulido et al. 2007).
However, the FTO gene is expressed in the hypothalamus
and regulated by fasting and leptin (Frayling et al. 2007;
Gerken et al. 2007). Using large-scale case-control asso-
ciation studies, we determined that the SCG3 (Tanabe et al.
2007) and MTMR9 (Yanagiya et al. 2007) genes are
involved in susceptibility to the obesity phenotype. These
two genes are expressed in the hypothalamus. Genetic
studies in mice have suggested that mutations in several
genes, such as those encoding leptin, proopiomelanocortin,
and melanocortin-4 receptor, are implicated in a mono-
genic form of inherited obesity (Barsh et al. 2000;
Rankinen et al. 2006). Such mutations have also been
reported in obese humans. As most such genes are
expressed in the hypothalamus and have been indicated to
play important roles in the regulation of food intake, genes
expressed in the hypothalamus are likely to be good can-
didates for susceptibility to obesity.
In summary, we have identiﬁed the genetic variations in
the FTO gene that may inﬂuence the risk of severe obesity
in the Japanese.
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